Skip to main content
PMC home page
Gut logoLink to Gut
. 1988 Mar;29(3):279–283. doi: 10.1136/gut.29.3.279

Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.

H Humphreys 1, S Bourke 1, C Dooley 1, D McKenna 1, B Power 1, C T Keane 1, E C Sweeney 1, C O'Moráin 1
PMCID: PMC1433591  PMID: 3356357

Abstract

This study investigated the effect of colloidal bismuth subcitrate and cimetidine on Campylobacter pylori in peptic disease. In 74% of 135 patients with peptic disease diagnosed at endoscopy C pylori was detected before treatment. Compared with cimetidine, colloidal bismuth subcitrate significantly decreased the incidence of C pylori after six weeks of treatment (p less than 0.001). In the colloidal bismuth subcitrate group, subsequent healing of the lesion was correlated with the clearance of C pylori, unlike in the cimetidine group. C pylori was strongly associated with the presence of histological gastritis, which was decreased by colloidal bismuth subcitrate (p less than 0.001).

Full text

PDF
279

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brogden R. N., Pinder R. M., Sawyer P. R., Speight T. M., Avery G. S. Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer. Drugs. 1976 Dec;12(6):401–411. doi: 10.2165/00003495-197612060-00001. [DOI] [PubMed] [Google Scholar]
  2. Goodwin C. S., Armstrong J. A., Marshall B. J. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol. 1986 Apr;39(4):353–365. doi: 10.1136/jcp.39.4.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goodwin C. S., Armstrong J. A. Will antibacterial chemotherapy be efficacious for gastritis and peptic ulcer? J Antimicrob Chemother. 1986 Jan;17(1):1–3. doi: 10.1093/jac/17.1.1. [DOI] [PubMed] [Google Scholar]
  4. Hamilton I., O'Connor H. J., Wood N. C., Bradbury I., Axon A. T. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut. 1986 Jan;27(1):106–110. doi: 10.1136/gut.27.1.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jones D. M., Lessells A. M., Eldridge J. Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. J Clin Pathol. 1984 Sep;37(9):1002–1006. doi: 10.1136/jcp.37.9.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985 Apr 15;142(8):436–439. doi: 10.5694/j.1326-5377.1985.tb113443.x. [DOI] [PubMed] [Google Scholar]
  7. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  8. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
  9. Martin D. F., Hollanders D., May S. J., Ravenscroft M. M., Tweedle D. E., Miller J. P. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet. 1981 Jan 3;1(8210):7–10. doi: 10.1016/s0140-6736(81)90114-8. [DOI] [PubMed] [Google Scholar]
  10. McNulty C. A., Dent J., Wise R. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother. 1985 Dec;28(6):837–838. doi: 10.1128/aac.28.6.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. O'Connor H. J., Axon A. T., Dixon M. F. Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet. 1984 Nov 10;2(8411):1091–1091. doi: 10.1016/s0140-6736(84)91523-x. [DOI] [PubMed] [Google Scholar]
  12. O'Connor H. J., Wyatt J. I., Dixon M. F., Axon A. T. Campylobacter like organisms and reflux gastritis. J Clin Pathol. 1986 May;39(5):531–534. doi: 10.1136/jcp.39.5.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Price A. B., Levi J., Dolby J. M., Dunscombe P. L., Smith A., Clark J., Stephenson M. L. Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut. 1985 Nov;26(11):1183–1188. doi: 10.1136/gut.26.11.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rollason T. P., Stone J., Rhodes J. M. Spiral organisms in endoscopic biopsies of the human stomach. J Clin Pathol. 1984 Jan;37(1):23–26. doi: 10.1136/jcp.37.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schrager J., Spink R., Mitra S. The antrum in patients with duodenal and gastric ulcers. Gut. 1967 Oct;8(5):497–508. doi: 10.1136/gut.8.5.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Soutar R. L., Coghill S. B. Interaction of tripotassium dicitrato bismuthate with macrophages in the rat and in vitro. Gastroenterology. 1986 Jul;91(1):84–93. doi: 10.1016/0016-5085(86)90443-9. [DOI] [PubMed] [Google Scholar]
  17. Steer H. W., Colin-Jones D. G. Mucosal changes in gastric ulceration and their response to carbenoxolone sodium. Gut. 1975 Aug;16(8):590–597. doi: 10.1136/gut.16.8.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Steer H. W. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut. 1984 Nov;25(11):1203–1210. doi: 10.1136/gut.25.11.1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Steer H. W. The gastro-duodenal epithelium in peptic ulceration. J Pathol. 1985 Aug;146(4):355–362. doi: 10.1002/path.1711460409. [DOI] [PubMed] [Google Scholar]
  20. Tatsuta M., Iishi H., Okuda S. Location of peptic ulcers in relation to antral and fundal gastritis by chromoendoscopic follow-up examinations. Dig Dis Sci. 1986 Jan;31(1):7–11. doi: 10.1007/BF01347902. [DOI] [PubMed] [Google Scholar]
  21. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  22. Vantrappen G., Rutgeerts P., Broeckaert L., Janssens J. Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Gut. 1980 Apr;21(4):329–333. doi: 10.1136/gut.21.4.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Zhao H. Y., Li G. Z., Guo J. D., Yan Z., Sun S. W., Li L. S., Duan Y. M., Yue F. Z. Furazolidone in peptic ulcer. Lancet. 1985 Aug 3;2(8449):276–277. [PubMed] [Google Scholar]
  24. Zheng Z. T., Wang Z. Y., Chu Y. X., Li Y. N., Li Q. F., Lin S. R., Xu Z. M. Double-blind short-term trial of furazolidone in peptic ulcer. Lancet. 1985 May 4;1(8436):1048–1049. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES